| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.86B | 63.74B | 43.63B | 40.76B | 37.12B | 30.21B |
| Gross Profit | 5.08B | 5.68B | 3.67B | 2.98B | 3.01B | -2.27B |
| EBITDA | 4.34B | 4.98B | 3.68B | 2.39B | 3.05B | -7.20B |
| Net Income | 618.65M | 766.00M | 632.95M | -1.14B | 513.57M | -8.71B |
Balance Sheet | ||||||
| Total Assets | 56.30B | 56.06B | 53.19B | 42.62B | 38.54B | 42.04B |
| Cash, Cash Equivalents and Short-Term Investments | 8.20B | 7.68B | 6.21B | 5.53B | 4.86B | 7.10B |
| Total Debt | 29.82B | 29.01B | 26.73B | 22.55B | 18.88B | 23.61B |
| Total Liabilities | 44.30B | 43.94B | 41.76B | 31.63B | 28.21B | 32.08B |
| Stockholders Equity | 12.00B | 12.12B | 11.43B | 10.99B | 10.32B | 9.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 315.94M | 2.32B | -1.09B | 2.34B | -7.88B |
| Operating Cash Flow | 0.00 | 3.51B | 4.83B | 1.61B | 3.82B | -5.42B |
| Investing Cash Flow | 0.00 | -3.16B | -4.52B | -4.24B | -1.42B | -2.93B |
| Financing Cash Flow | 0.00 | 1.09B | 436.06M | 3.35B | -4.56B | 9.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥161.64B | 14.48 | ― | 1.78% | 4.04% | 4.80% | |
71 Outperform | ¥40.27B | 6.30 | ― | 1.42% | 10.96% | 75.10% | |
66 Neutral | ¥21.60B | 7.10 | ― | 0.76% | 20.69% | 17.46% | |
63 Neutral | ¥386.94B | 21.16 | 10.65% | 1.64% | 14.75% | 22.10% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | ¥6.31B | 12.92 | ― | 2.41% | <0.01% | 23.81% | |
54 Neutral | ¥19.77B | 10.29 | ― | 1.12% | 19.01% | -18.93% |